The Mirror New appetite-suppressing pill by makers of the ‘King Kong’ of weight loss jabs
Trial results published in the Lancet suggest the new appetite suppressing pill by pharmaceutical giant Eli Lilly worked best for patients with Type 2 diabetes, with two positive outcomes